By combining advanced labs with open access to biobanking and research tools, Coriell’s new campus positions Camden as a vital extension of the Greater Philadelphia life sciences ecosystem.
When the Coriell Institute for Medical Research broke ground on its new life sciences campus in Camden earlier this month, the moment represented more than a new building — it marked a strategic investment in the infrastructure that fuels R&D, biobanking, and biotech collaboration across the Greater Philadelphia region.
Located just across the Delaware River from Center City, Camden’s new Coriell Life Sciences Campus will anchor a growing corridor of biomedical innovation that ties together South Jersey and Philadelphia’s thriving biotech ecosystem.
Coriell President and CEO Dr. Jean-Pierre Issa described the project as an opportunity to “dream bigger” — to reimagine what it means to support modern science and innovation. The new 92,000-square-foot campus, slated to open in early 2028, will consolidate Coriell’s world-renowned biobanking operations, expand its research programs, and introduce a first-of-its-kind innovation center designed specifically for early-stage biotech companies.
A Unique Convergence of R&D, Biobanking, and Startup Acceleration
What makes this project stand out is its multi-layered design: part advanced research facility, part innovation incubator, part biobank. This convergence isn’t accidental — it’s strategic.
Coriell’s globally recognized biorepository has long served as a backbone of biomedical research, supplying biospecimens and cell lines to thousands of scientists worldwide. By physically co-locating that infrastructure with state-of-the-art labs and startup space, the new campus creates a dynamic feedback loop between discovery, application, and commercialization.
Roughly half of the building will be devoted to the NJ Coriell Labs Innovation Center, established in partnership with the New Jersey Economic Development Authority’s Strategic Innovation Center (SIC) program. The center will provide wet-lab space, shared equipment, and collaborative infrastructure for biotech startups — particularly those focused on genomics, cell therapy, and precision medicine.
Governor Phil Murphy emphasized this ambition, saying, “With the addition of the NJ Coriell Labs Innovation Center, we are not only expanding New Jersey’s innovation economy — we are setting a new standard.” Camden Mayor Victor Carstarphen added, “This will be a tremendous economic boost to our city, South Jersey, and the region.” [NJBIZ].
Bridging the River — and the Ecosystem
While Camden is technically in New Jersey, its proximity to Philadelphia places this initiative squarely within the Greater Philadelphia life sciences network. The region’s scientific and startup communities already move fluidly between the city’s academic institutions, suburban R&D parks, and South Jersey’s manufacturing and logistics base.
Coriell’s new campus strengthens that connectivity. It offers Philadelphia-based startups new access to specialized biobanking resources and lab infrastructure without the overhead of building their own. For established companies, it opens collaboration opportunities with one of the world’s leading genomic research organizations.
From a regional growth perspective, this project is a model for how cross-border alignment can expand capacity and resilience. By leveraging public-private partnerships and geographic synergy, the Coriell campus will help bridge historical silos and strengthen the shared identity of the Greater Philadelphia life sciences corridor.
Why This Matters
This development represents more than bricks and glass — it’s infrastructure for collaboration. It’s an intentional design that supports the full continuum of biotech innovation: from basic research and specimen banking to translational science and startup formation.
As Coriell prepares to expand its footprint, it’s also redefining how regions can grow together. Camden’s evolution from an underrepresented node to a research anchor shows what’s possible when investment aligns with mission — and when an institution like Coriell commits to building not just for itself, but for the ecosystem around it.
For Greater Philadelphia’s life sciences community, the message is clear: the innovation map is expanding, and the next big biotech breakthrough might just start across the river.
